BCHE and Parkinson disease: Another limitation is that 15 out of 16 of the DLB patients were on cholinesterase inhibitors which may have biased our findings; for example Possin et al. (2013) found restored resting state activity compared to healthy controls with improvements in controlled attention in Parkinson's disease patients under rivastigmine treatment.